Duodenal Ulcer
📧 Sign up to get email alerts when something new happens for Duodenal Ulcer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-04-16FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Lansoprazole from Teva Pharmaceuticals USA, Inc. The submission concerns a supplemental chan…
-
FDA approval · 2012-03-23FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
FDA approves Apotex Corp's supplemental application for omeprazole (generic) under ANDA076048. This authorizes the marketing of a generic om…
-
FDA approval · 2012-02-29FDA Approved: ACID REDUCER — Original Application (WinCo Foods, LLC)
FDA approved an original application for a generic ranitidine hydrochloride product called ACID REDUCER by WinCo Foods, LLC.
-
FDA approval · 2012-02-16FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for omeprazole from Lannett Company, Inc., authorizing a generic omeprazole product.
-
FDA approval · 2012-02-14FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole from Sandoz Inc, confirming an update to the approved generic product labeling. This …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-02-13FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for omeprazole submitted by Sandoz Inc under ANDA075757 (generic omeprazole).
-
CLINICAL_TRIALS trial_result · 2012-02-13Clinical Trial Update: Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA) [Phase 3]
Phase 3 trial comparing esomeprazole 20 mg or 40 mg with placebo to prevent peptic ulcers in subjects taking low-dose aspirin; results poste…
-
FDA approval · 2012-02-09FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for a generic omeprazole product from Quallent Pharmaceuticals Health LLC under ANDA075576. This…
-
FDA approval · 2012-01-31FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr.Reddy's Laboratories Ltd.)
FDA approved a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Ltd.
-
FDA approval · 2012-01-20FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca, updating the labeling under a supplemental…
-
FDA approval · 2012-01-17FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Pantoprazole Sodium by Torrent Pharmaceuticals Limited. The approval denotes changes under a sup…
-
FDA approval · 2012-01-11FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for pantoprazole submitted by NorthStar RxLLC.
-
CLINICAL_TRIALS trial_result · 2012-01-10Clinical Trial Update: The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients [Phase 4]
This Phase 4 trial assesses the safety and efficacy of Albis in preventing aspirin-induced gastrointestinal ulcers in patients taking low-do…
-
FDA approval · 2011-12-15FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2011-12-07FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for Oceanside Pharmaceuticals' omeprazole and sodium bicarbonate, updating labeling through a supple…
-
CLINICAL_TRIALS trial_result · 2011-11-15Clinical Trial Update: Prophylactic Injection Therapy Reduces Recurrent Bleeding In Forrest Type IIb Duodenal Ulcers [NA]
A completed clinical trial reports that prophylactic injection therapy reduces recurrent bleeding in Forrest type IIb duodenal ulcers.
-
FDA approval · 2011-10-31FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer).
-
FDA approval · 2011-10-28FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID SOLUTAB (lansoprazole) submitted by Takeda Pharmaceuticals America, Inc. The action…
-
FDA approval · 2011-07-31FDA Approved: NIZATIDINE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for nizatidine from Epic Pharma, LLC (ANDA 076178). This marks approval of a supplemental update for…
-
FDA approval · 2011-06-07FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to authorize the intravenous formulation of Protonix (pantoprazole sodium) from Wyeth Pharmaceut…
-
FDA approval · 2011-06-01FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID SOLUTAB (lansoprazole) to add a Solutab formulation, submitted by Takeda Pharmaceut…
-
FDA label_change · 2011-05-20FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth/Pfizer to update the product labeling.
-
FDA label_change · 2011-05-20FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
FDA approved a supplemental application for ACIPHEX (rabeprazole sodium) submitted by Waylis Therapeutics LLC to update the product labeling…
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs [Phase 3]
Phase 3 trial evaluating the efficacy and safety of lansoprazole for NSAID-associated gastric and duodenal ulcers, with results posted.
-
CLINICAL_TRIALS trial_result · 2011-05-10Clinical Trial Update: A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers [Phase 3]
Phase 3 trial evaluating lansoprazole to prevent aspirin-induced gastric and duodenal ulcers was terminated; results have been posted.